Fumonisin B1: Oxidative status and DNA damage in rats

Ana Marija Domijan, Davor Želježić, Mirta Milić, Maja Peraica

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Fumonisin B1 (FB1) is a carcinogenic mycotoxin involved in several animal diseases and assumed to be involved in the etiology of some human tumors. FB1 disturbs the metabolism of sphinganine (Sa) and sphingosine (So), increasing the ratio of their concentrations (Sa/So). FB1 is mutagenic in cell cultures, but the mechanism of its genotoxicity is not understood. The aim of this study was to see whether DNA lesions in kidney and liver cells of rats treated with FB1 were related to the changes in the oxidative status or to the disturbance of the sphingolipid metabolism. Male Wistar rats were receiving either FB1 (0.5 mg/kg b.w./day, i.p. for 2 or 7 days) or solvent only and were sacrificed 24 h after the last treatment. The ratio of Sa and So concentrations and parameters of oxidative status (catalytic activity of catalase and the concentrations of protein carbonyls and malondialdehyde, MDA) were measured in plasma and liver and kidney homogenates, while DNA damage was measured in liver and kidney using the comet assay. In plasma and liver and kidney homogenates catalase activity and the concentrations of protein carbonyls and MDA were not affected by the 2-day treatment with FB1, but the ratio of Sa and So in plasma and liver and kidney homogenates was significantly higher than in controls (0.99 ± 0.27 versus 0.38 ± 0.08, 1.05 ± 0.12 versus 0.59 ± 0.09 and 4.51 ± 0.51 versus 0.54 ± 0.17, respectively) (p <0.05). After the 2-day treatment, the tail length and tail intensity measured with the comet assay in the liver homogenate did not change, while in the kidney homogenate, the difference between the treated and control animals was significant in both the tail length (26.4 ± 0.7 μm versus 14.6 ± 0.1 μm) and tail intensity (8.0 ± 0.4% versus 1.7 ± 0.02% DNA) (p <0.05). After the 7-day treatment all measured parameters significantly differed from controls (p <0.05). This study showed that FB1 causes DNA lesions in the kidney of experimental animals before affecting the catalytic activity of catalase and the concentration of protein carbonyls and MDA. The ratio of Sa and So significantly increases in all tissues already after 2-day treatment thus indicating that the metabolism of sphingolipids may have an important role in the DNA damage caused by FB1.

Original languageEnglish
Pages (from-to)163-169
Number of pages7
JournalToxicology
Volume232
Issue number3
DOIs
Publication statusPublished - Apr 11 2007

Fingerprint

DNA Damage
Rats
Sphingosine
Liver
Kidney
DNA
Tail
Metabolism
Catalase
Sphingolipids
Animals
Comet Assay
Plasmas
Assays
Catalyst activity
Animal Diseases
Proteins
fumonisin B1
Mycotoxins
Malondialdehyde

Keywords

  • Catalase
  • Comet assay
  • Malondialdehyde
  • Micronucleus assay
  • Mycotoxins
  • Protein carbonyls

ASJC Scopus subject areas

  • Toxicology

Cite this

Domijan, A. M., Želježić, D., Milić, M., & Peraica, M. (2007). Fumonisin B1: Oxidative status and DNA damage in rats. Toxicology, 232(3), 163-169. https://doi.org/10.1016/j.tox.2007.01.007

Fumonisin B1 : Oxidative status and DNA damage in rats. / Domijan, Ana Marija; Želježić, Davor; Milić, Mirta; Peraica, Maja.

In: Toxicology, Vol. 232, No. 3, 11.04.2007, p. 163-169.

Research output: Contribution to journalArticle

Domijan, AM, Želježić, D, Milić, M & Peraica, M 2007, 'Fumonisin B1: Oxidative status and DNA damage in rats', Toxicology, vol. 232, no. 3, pp. 163-169. https://doi.org/10.1016/j.tox.2007.01.007
Domijan AM, Želježić D, Milić M, Peraica M. Fumonisin B1: Oxidative status and DNA damage in rats. Toxicology. 2007 Apr 11;232(3):163-169. https://doi.org/10.1016/j.tox.2007.01.007
Domijan, Ana Marija ; Želježić, Davor ; Milić, Mirta ; Peraica, Maja. / Fumonisin B1 : Oxidative status and DNA damage in rats. In: Toxicology. 2007 ; Vol. 232, No. 3. pp. 163-169.
@article{538b636927ba4921a82567b8c8855c27,
title = "Fumonisin B1: Oxidative status and DNA damage in rats",
abstract = "Fumonisin B1 (FB1) is a carcinogenic mycotoxin involved in several animal diseases and assumed to be involved in the etiology of some human tumors. FB1 disturbs the metabolism of sphinganine (Sa) and sphingosine (So), increasing the ratio of their concentrations (Sa/So). FB1 is mutagenic in cell cultures, but the mechanism of its genotoxicity is not understood. The aim of this study was to see whether DNA lesions in kidney and liver cells of rats treated with FB1 were related to the changes in the oxidative status or to the disturbance of the sphingolipid metabolism. Male Wistar rats were receiving either FB1 (0.5 mg/kg b.w./day, i.p. for 2 or 7 days) or solvent only and were sacrificed 24 h after the last treatment. The ratio of Sa and So concentrations and parameters of oxidative status (catalytic activity of catalase and the concentrations of protein carbonyls and malondialdehyde, MDA) were measured in plasma and liver and kidney homogenates, while DNA damage was measured in liver and kidney using the comet assay. In plasma and liver and kidney homogenates catalase activity and the concentrations of protein carbonyls and MDA were not affected by the 2-day treatment with FB1, but the ratio of Sa and So in plasma and liver and kidney homogenates was significantly higher than in controls (0.99 ± 0.27 versus 0.38 ± 0.08, 1.05 ± 0.12 versus 0.59 ± 0.09 and 4.51 ± 0.51 versus 0.54 ± 0.17, respectively) (p <0.05). After the 2-day treatment, the tail length and tail intensity measured with the comet assay in the liver homogenate did not change, while in the kidney homogenate, the difference between the treated and control animals was significant in both the tail length (26.4 ± 0.7 μm versus 14.6 ± 0.1 μm) and tail intensity (8.0 ± 0.4{\%} versus 1.7 ± 0.02{\%} DNA) (p <0.05). After the 7-day treatment all measured parameters significantly differed from controls (p <0.05). This study showed that FB1 causes DNA lesions in the kidney of experimental animals before affecting the catalytic activity of catalase and the concentration of protein carbonyls and MDA. The ratio of Sa and So significantly increases in all tissues already after 2-day treatment thus indicating that the metabolism of sphingolipids may have an important role in the DNA damage caused by FB1.",
keywords = "Catalase, Comet assay, Malondialdehyde, Micronucleus assay, Mycotoxins, Protein carbonyls",
author = "Domijan, {Ana Marija} and Davor Želježić and Mirta Milić and Maja Peraica",
year = "2007",
month = "4",
day = "11",
doi = "10.1016/j.tox.2007.01.007",
language = "English",
volume = "232",
pages = "163--169",
journal = "Toxicology",
issn = "0300-483X",
publisher = "Elsevier Ireland Ltd",
number = "3",

}

TY - JOUR

T1 - Fumonisin B1

T2 - Oxidative status and DNA damage in rats

AU - Domijan, Ana Marija

AU - Želježić, Davor

AU - Milić, Mirta

AU - Peraica, Maja

PY - 2007/4/11

Y1 - 2007/4/11

N2 - Fumonisin B1 (FB1) is a carcinogenic mycotoxin involved in several animal diseases and assumed to be involved in the etiology of some human tumors. FB1 disturbs the metabolism of sphinganine (Sa) and sphingosine (So), increasing the ratio of their concentrations (Sa/So). FB1 is mutagenic in cell cultures, but the mechanism of its genotoxicity is not understood. The aim of this study was to see whether DNA lesions in kidney and liver cells of rats treated with FB1 were related to the changes in the oxidative status or to the disturbance of the sphingolipid metabolism. Male Wistar rats were receiving either FB1 (0.5 mg/kg b.w./day, i.p. for 2 or 7 days) or solvent only and were sacrificed 24 h after the last treatment. The ratio of Sa and So concentrations and parameters of oxidative status (catalytic activity of catalase and the concentrations of protein carbonyls and malondialdehyde, MDA) were measured in plasma and liver and kidney homogenates, while DNA damage was measured in liver and kidney using the comet assay. In plasma and liver and kidney homogenates catalase activity and the concentrations of protein carbonyls and MDA were not affected by the 2-day treatment with FB1, but the ratio of Sa and So in plasma and liver and kidney homogenates was significantly higher than in controls (0.99 ± 0.27 versus 0.38 ± 0.08, 1.05 ± 0.12 versus 0.59 ± 0.09 and 4.51 ± 0.51 versus 0.54 ± 0.17, respectively) (p <0.05). After the 2-day treatment, the tail length and tail intensity measured with the comet assay in the liver homogenate did not change, while in the kidney homogenate, the difference between the treated and control animals was significant in both the tail length (26.4 ± 0.7 μm versus 14.6 ± 0.1 μm) and tail intensity (8.0 ± 0.4% versus 1.7 ± 0.02% DNA) (p <0.05). After the 7-day treatment all measured parameters significantly differed from controls (p <0.05). This study showed that FB1 causes DNA lesions in the kidney of experimental animals before affecting the catalytic activity of catalase and the concentration of protein carbonyls and MDA. The ratio of Sa and So significantly increases in all tissues already after 2-day treatment thus indicating that the metabolism of sphingolipids may have an important role in the DNA damage caused by FB1.

AB - Fumonisin B1 (FB1) is a carcinogenic mycotoxin involved in several animal diseases and assumed to be involved in the etiology of some human tumors. FB1 disturbs the metabolism of sphinganine (Sa) and sphingosine (So), increasing the ratio of their concentrations (Sa/So). FB1 is mutagenic in cell cultures, but the mechanism of its genotoxicity is not understood. The aim of this study was to see whether DNA lesions in kidney and liver cells of rats treated with FB1 were related to the changes in the oxidative status or to the disturbance of the sphingolipid metabolism. Male Wistar rats were receiving either FB1 (0.5 mg/kg b.w./day, i.p. for 2 or 7 days) or solvent only and were sacrificed 24 h after the last treatment. The ratio of Sa and So concentrations and parameters of oxidative status (catalytic activity of catalase and the concentrations of protein carbonyls and malondialdehyde, MDA) were measured in plasma and liver and kidney homogenates, while DNA damage was measured in liver and kidney using the comet assay. In plasma and liver and kidney homogenates catalase activity and the concentrations of protein carbonyls and MDA were not affected by the 2-day treatment with FB1, but the ratio of Sa and So in plasma and liver and kidney homogenates was significantly higher than in controls (0.99 ± 0.27 versus 0.38 ± 0.08, 1.05 ± 0.12 versus 0.59 ± 0.09 and 4.51 ± 0.51 versus 0.54 ± 0.17, respectively) (p <0.05). After the 2-day treatment, the tail length and tail intensity measured with the comet assay in the liver homogenate did not change, while in the kidney homogenate, the difference between the treated and control animals was significant in both the tail length (26.4 ± 0.7 μm versus 14.6 ± 0.1 μm) and tail intensity (8.0 ± 0.4% versus 1.7 ± 0.02% DNA) (p <0.05). After the 7-day treatment all measured parameters significantly differed from controls (p <0.05). This study showed that FB1 causes DNA lesions in the kidney of experimental animals before affecting the catalytic activity of catalase and the concentration of protein carbonyls and MDA. The ratio of Sa and So significantly increases in all tissues already after 2-day treatment thus indicating that the metabolism of sphingolipids may have an important role in the DNA damage caused by FB1.

KW - Catalase

KW - Comet assay

KW - Malondialdehyde

KW - Micronucleus assay

KW - Mycotoxins

KW - Protein carbonyls

UR - http://www.scopus.com/inward/record.url?scp=33947331731&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33947331731&partnerID=8YFLogxK

U2 - 10.1016/j.tox.2007.01.007

DO - 10.1016/j.tox.2007.01.007

M3 - Article

C2 - 17291664

AN - SCOPUS:33947331731

VL - 232

SP - 163

EP - 169

JO - Toxicology

JF - Toxicology

SN - 0300-483X

IS - 3

ER -